Skip to main content
Top

Multi-center investigation on the influence of clinical characteristics and molecular group A streptococci diagnostics on the management of tonsillopharyngitis in pediatric practices in Berlin—BASE study

Published in:

Abstract

A clear distinction between viral, bacterial, or non-infectious tonsillopharyngitis is not always possible due to overlapping clinical symptoms. Patient near point-of-care diagnostics may contribute to supporting clinical assessment and, in turn, guide antibiotic treatment. We performed a prospective cluster-randomized multi-center study with cross-over design in 25 pediatric offices located in and around the city of Berlin, Germany, from December 2023 to May 2024. The primary objective was to determine whether using a rapid molecular point of care test (mPOC) reduces antibiotic prescription rates in children 3 to <18 years of age with febrile tonsillopharyngitis. As a secondary objective, sick days, re-assessments, and hospitalizations were evaluated. A total of 1111 patients were included in the final analysis. A positive test result in the mPOC group was observed in 67.1% (n = 471/702) and 65.8% (n = 194/295) in the standard care (SC) control group (which had optional rapid antigen testing). Interestingly, only 27.9% (n = 114/409) of children in the SC group were managed exclusively on a clinical diagnosis. Overall, two-thirds of all patients received a prescription for antibiotics (67.2%; n = 747/1111), with no significant difference between the study groups. In 95.5% (n = 635/665) of children with a positive test, an antibiotic was prescribed, as well as in 10.8% (n = 36/332) of test-negative cases. The probability of prescribing antibiotics was significantly higher when the McIsaac score was ≥3 (OR =4.67 (CI 95% 3.22–6.79, p < 0.0001)). In patients <5 years, the number of sick leave days was 37% higher than in older ones (IRR = 1.37 (95% CI 1.18–1.59, p<0.0001)). Conclusion: A McIsaac score ≥ 3 and a positive streptococcal test result were strong drivers for antibiotic prescription. No difference in antibiotic prescription rates between study groups was observed. Antibiotic usage was high in our patient cohort and requires further efforts regarding diagnostic and antibiotic stewardship. Tonsillopharyngitis also utilized substantial resources during follow-up.
What is Known:
A clear distinction between viral, bacterial, or non-infectious pharyngitis is not always possible due to the overlapping clinical symptoms.
Rapid antigen tests (RADT) or molecular diagnostic tests (mPOC) as part of point-of-care testing may contribute to antibiotic treatment guidance.
What is New:
In children with febrile tonsillopharyngitis, we could not observe a reduction in antibiotic prescription rates using mPOC compared to routine care, including RADT.
Further efforts regarding diagnostic and antibiotic stewardship are warranted.
Trial registration number (DRKS-ID): DRKS00034362.
Title
Multi-center investigation on the influence of clinical characteristics and molecular group A streptococci diagnostics on the management of tonsillopharyngitis in pediatric practices in Berlin—BASE study
Authors
Helena Hain
Viviane Jeanbat
Camille Nevoret
Isabelle Bureau
Tobias Tenenbaum
Publication date
01-03-2026
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Pediatrics / Issue 3/2026
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-026-06818-5
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Mini masterclass: enhancing outcomes in LGS (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

These six bite-sized videos will equip you with insights into the pathophysiological processes underlying Lennox–Gastaut syndrome, the burden on patients and caregivers, and opportunities to increase diagnostic accuracy and optimize treatment strategies.

Independent Medical Education Grant:
  • Jazz Pharmaceuticals
Watch now Link opens in a new window

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Watch now
Video
Image Credits
Enchancing Lennox-Gastaut Syndrome program image/© Springer Health+ IME, Person in orange t-shirt using an e-cigarette/© licsiren / Getty Images / iStock (symbolic image with model)